NutraCea Announces Second Quarter Conference Call
* Reuters is not responsible for the content in this press release.
Company Reconfirms Revenue Guidance for Second Quarter
PHOENIX, July 31 /PRNewswire-FirstCall/ -- NutraCea
(OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB),
nutrient research and technology, announced today that it will release its
second quarter results on Monday, August 11, 2008, after market close.
Management will host a conference call at 5:30 p.m. ET on Monday, August
11 to review second quarter financial results. Interested parties should dial
800-257-1927. International callers should dial 303-262-2138
The call is also available via a Webcast that can be accessed at:
http://www.investorcalendar.com/IC/CEPage.asp?ID=132444 and will be archived
for 30 days.
The Company previously provided guidance on the first quarter conference
call May 12, 2008 for revenues for the second quarter to be between $9 and $10
million. The Company is pleased to report that it will meet or exceed this
guidance for the second quarter and that all of its previously announced
construction projects are on schedule.
Management is continuing to evaluate various financing options available
to them to fund the construction of the world's largest rice bran oil refinery
in China and expects to announce the appropriate financing option before
September 30, 2008.
About NutraCea
NutraCea is a leader in stabilized rice bran nutrient research and dietary
supplement development. Through its wholly owned subsidiary, RiceX, the
Company manufactures and distributes products and food ingredients made from
rice bran through its proprietary technology and processes. NutraCea has
developed intellectual properties to create a range of proprietary product
formulations, delivery systems and whole food nutrition products. The
Company's proprietary technology enables the creation of food and nutrition
products from rice bran, normally an underutilized by-product of standard rice
processing. In addition to its whole foods products, NutraCea develops
families of health-promoting "nutraceuticals," including natural arthritis
relief and cholesterol-lowering products. More information can be found in the
Company's filings with the SEC and at its Web site http://www.NutraCea.com.
Forward-Looking Statements
This release contains forward-looking statements, including, but not
limited to, statements regarding the rice oil refinery in China, and the
expected announcement of the appropriate financing option for the construction
of that facility, which statements are subject to many market, governmental
regulation, and other risks. These statements are made based upon current
expectations and actual results may differ from those projected, due to
various risks and uncertainties. The Company does not undertake to update
forward-looking statements in this news release to reflect actual results,
changes in assumptions or changes in other factors affecting such
forward-looking information. Assumptions and other information that could
cause results to differ from those set forth in the forward-looking
information can be found in the Company's filings with the Securities and
Exchange Commission, including the Company's most recent periodic reports.
Investor Relations Contact:
Marilynn Meek
Financial Relations Board
212-827-3773
mmeek@frbir.com
SOURCE NutraCea
Investor Relations, Marilynn Meek of Financial Relations Board,
+1-212-827-3773, mmeek@frbir.com, for NutraCea
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters